| Identification of the hemogenic endothelial progenitor and its direct precursor in human pluripotent stem cell differentiation cultures KD Choi, MA Vodyanik, PP Togarrati, K Suknuntha, A Kumar, F Samarjeet, ... Cell reports 2 (3), 553-567, 2012 | 260 | 2012 |
| Specification and diversification of pericytes and smooth muscle cells from mesenchymoangioblasts A Kumar, SS D’Souza, OV Moskvin, H Toh, B Wang, J Zhang, S Swanson, ... Cell reports 19 (9), 1902-1916, 2017 | 222 | 2017 |
| Direct induction of haematoendothelial programs in human pluripotent stem cells by transcriptional regulators I Elcheva, V Brok-Volchanskaya, A Kumar, P Liu, JH Lee, L Tong, ... Nature communications 5 (1), 4372, 2014 | 221 | 2014 |
| NOTCH signaling specifies arterial-type definitive hemogenic endothelium from human pluripotent stem cells GI Uenishi, HS Jung, A Kumar, MA Park, BK Hadland, E McLeod, ... Nature communications 9 (1), 1828, 2018 | 118 | 2018 |
| Tenascin C promotes hematoendothelial development and T lymphoid commitment from human pluripotent stem cells in chemically defined conditions G Uenishi, D Theisen, JH Lee, A Kumar, M Raymond, M Vodyanik, ... Stem cell reports 3 (6), 1073-1084, 2014 | 113 | 2014 |
| Activation of the arterial program drives development of definitive hemogenic endothelium with lymphoid potential MA Park, A Kumar, HS Jung, G Uenishi, OV Moskvin, JA Thomson, ... Cell reports 23 (8), 2467-2481, 2018 | 65 | 2018 |
| Antiangiogenic and proapoptotic activities of allyl isothiocyanate inhibit ascites tumor growth in vivo A Kumar, SS D'Souza, S Tickoo, BP Salimath, HB Singh Integrative Cancer Therapies 8 (1), 75-87, 2009 | 65 | 2009 |
| Platelet-derived growth factor receptor signaling is not involved in osteogenic differentiation of human mesenchymal stem cells A Kumar, BP Salimath, GB Stark, G Finkenzeller Tissue Engineering Part A 16 (3), 983-993, 2010 | 60 | 2010 |
| Growth inhibition and induction of apoptosis in MCF-7 breast cancer cells by a new series of substituted-1, 3, 4-oxadiazole derivatives A Kumar, SS D’Souza, SL Gaonkar, KML Rai, BP Salimath Investigational new drugs 26, 425-435, 2008 | 56 | 2008 |
| Quadruple gene-engineered natural killer cells enable multi-antigen targeting for durable antitumor activity against multiple myeloma F Cichocki, R Bjordahl, JP Goodridge, S Mahmood, S Gaidarova, ... Nature communications 13 (1), 7341, 2022 | 52 | 2022 |
| 3D iPSC modeling of the retinal pigment epithelium-choriocapillaris complex identifies factors involved in the pathology of macular degeneration KV Manian, CA Galloway, S Dalvi, AA Emanuel, JA Mereness, W Black, ... Cell Stem Cell 28 (5), 846-862. e8, 2021 | 50 | 2021 |
| The mesenchymoangioblast, mesodermal precursor for mesenchymal and endothelial cells II Slukvin, A Kumar Cellular and Molecular Life Sciences 75, 3507-3520, 2018 | 48 | 2018 |
| Antiangiogenic and antiproliferative effects of substituted-1, 3, 4-oxadiazole derivatives is mediated by down regulation of VEGF and inhibition of translocation of HIF-1α in … A Kumar, SS D’Souza, SR Mysore Nagaraj, SL Gaonkar, BP Salimath, ... Cancer chemotherapy and pharmacology 64, 1221-1233, 2009 | 48 | 2009 |
| Understanding the journey of human hematopoietic stem cell development A Kumar, SS D’Souza, AS Thakur Stem cells international 2019 (1), 2141475, 2019 | 41 | 2019 |
| Optimization of synthetic mRNA for highly efficient translation and its application in the generation of endothelial and hematopoietic cells from human and primate pluripotent … K Suknuntha, L Tao, V Brok-Volchanskaya, SS D’Souza, A Kumar, ... Stem cell reviews and reports 14, 525-534, 2018 | 37 | 2018 |
| GSK3β inhibition promotes efficient myeloid and lymphoid hematopoiesis from non-human primate-induced pluripotent stem cells SS D'Souza, J Maufort, A Kumar, J Zhang, K Smuga-Otto, JA Thomson, ... Stem cell reports 6 (2), 243-256, 2016 | 35 | 2016 |
| Strategies facilitating the permeation of nanoparticles through blood-brain barrier: An insight towards the development of brain-targeted drug delivery system A Mishra, R Kumar, J Mishra, K Dutta, P Ahlawat, A Kumar, ... Journal of Drug Delivery Science and Technology 86, 104694, 2023 | 29 | 2023 |
| WHO Expert Committee on specifications for pharmaceutical preparations I Addae-Mensah, K Bremer, AA Haggag, J Shaohong, A Poompanich, ... Technical Report Series-World Health Organization, Geneva, i-136-i-136, 2003 | 24 | 2003 |
| Nicotinamide enhances natural killer cell function and yields remissions in patients with non-Hodgkin lymphoma F Cichocki, B Zhang, CY Wu, E Chiu, A Day, RS O’Connor, D Yackoubov, ... Science translational medicine 15 (705), eade3341, 2023 | 21 | 2023 |
| MTA1 induced angiogenesis, migration and tumor growth is inhibited by Glycyrrhiza glabra SRM Nagaraj, SM Lingaraj, Y Balaraju, A Kumar, BP Salimath IOSR J Pharmacy 2, 34-43, 2012 | 19 | 2012 |